• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cardiopulmonary bypass strategy with low-dose heparin and nafamostat mesilate in cardiac surgery: a safe option for patients with acute stroke.

作者信息

Morimoto Naoto, Henmi Soichiro, Yoshida Masato, Mukohara Nobuhiko

机构信息

Department of Cardiovascular Surgery, Himeji Cardiovascular Center, Himeji, Japan.

出版信息

J Thorac Cardiovasc Surg. 2012 Sep;144(3):726-8. doi: 10.1016/j.jtcvs.2012.03.030. Epub 2012 Apr 25.

DOI:10.1016/j.jtcvs.2012.03.030
PMID:22541513
Abstract
摘要

相似文献

1
Cardiopulmonary bypass strategy with low-dose heparin and nafamostat mesilate in cardiac surgery: a safe option for patients with acute stroke.心脏手术中低剂量肝素和甲磺酸萘莫司他的体外循环策略：急性中风患者的安全选择
J Thorac Cardiovasc Surg. 2012 Sep;144(3):726-8. doi: 10.1016/j.jtcvs.2012.03.030. Epub 2012 Apr 25.
2
Nafamostat mesilate, as a treatment for heparin resistance, is not associated with perioperative ischemic stroke in patients undergoing cardiac surgery with cardiopulmonary bypass.甲磺酸萘莫司他治疗肝素抵抗与体外循环心脏手术患者围术期缺血性卒中无关。
J Cardiothorac Vasc Anesth. 2012 Apr;26(2):239-44. doi: 10.1053/j.jvca.2011.09.002. Epub 2011 Oct 22.
3
Efficacy of nafamostat mesilate as anticoagulation during cardiopulmonary bypass for early surgery in patients with active infective endocarditis complicated by stroke.甲磺酸萘莫司他在伴有卒中的活动性感染性心内膜炎患者早期手术体外循环期间作为抗凝剂的疗效。
J Heart Valve Dis. 2014 Nov;23(6):744-51.
4
Effects of nafamostat mesilate and minimal-dose aprotinin on blood-foreign surface interactions in cardiopulmonary bypass.甲磺酸萘莫司他和最小剂量抑肽酶对体外循环中血液与异物表面相互作用的影响。
Ann Thorac Surg. 2004 Feb;77(2):644-50. doi: 10.1016/S0003-4975(03)01513-3.
5
Cardiopulmonary bypass using nafamostat mesilate for patients with infective endocarditis and recent intracranial hemorrhage.使用甲磺酸萘莫司他进行体外循环治疗感染性心内膜炎合并近期颅内出血的患者。
Interact Cardiovasc Thorac Surg. 2007 Jun;6(3):270-3. doi: 10.1510/icvts.2006.146209. Epub 2007 Feb 14.
6
Safety and Tolerability of Nafamostat Mesilate and Heparin as Anticoagulants in Leukocytapheresis for Ulcerative Colitis: Post Hoc Analysis of a Large-Scale, Prospective, Observational Study.甲磺酸萘莫司他与肝素作为溃疡性结肠炎白细胞单采术中抗凝剂的安全性和耐受性：一项大规模、前瞻性、观察性研究的事后分析
Ther Apher Dial. 2016 Apr;20(2):197-204. doi: 10.1111/1744-9987.12357. Epub 2016 Jan 14.
7
Reoperative sternotomy: minimizing injury without the risks of systemic heparin.
J Thorac Cardiovasc Surg. 2011 Apr;141(4):1085; author reply 1085. doi: 10.1016/j.jtcvs.2010.11.049.
8
Heparinized cardiopulmonary bypass circuits and low systemic anticoagulation: an analysis of nearly 6000 patients undergoing coronary artery bypass grafting.肝素化心肺转流回路和低全身抗凝：近 6000 例冠状动脉旁路移植术患者的分析。
J Thorac Cardiovasc Surg. 2011 May;141(5):1145-9. doi: 10.1016/j.jtcvs.2010.07.003. Epub 2010 Aug 14.
9
A comparison of low vs conventional-dose heparin for minimal cardiopulmonary bypass in coronary artery bypass grafting surgery.比较小剂量肝素与常规剂量肝素在冠状动脉旁路移植术中应用于体外循环最低限度的效果。
Anaesthesia. 2011 Jun;66(6):488-92. doi: 10.1111/j.1365-2044.2011.06709.x. Epub 2011 Apr 18.
10
Use of nafamostat mesilate as an anticoagulant during extracorporeal membrane oxygenation.使用甲磺酸萘莫司他作为体外膜肺氧合期间的抗凝剂。
J Korean Med Sci. 2011 Jul;26(7):945-50. doi: 10.3346/jkms.2011.26.7.945. Epub 2011 Jun 20.

引用本文的文献

1
New strategy of early surgery for infective endocarditis complicated by intracranial hemorrhage.感染性心内膜炎合并颅内出血的早期手术新策略。
Surg Today. 2025 Jun;55(6):795-802. doi: 10.1007/s00595-024-02964-1. Epub 2024 Nov 27.
2
Management of cardiopulmonary bypass in patients with ischemic and hemorrhagic strokes in surgery for active infective endocarditis.活动性感染性心内膜炎手术中合并缺血性和出血性卒中患者的体外循环管理
Indian J Thorac Cardiovasc Surg. 2024 May;40(Suppl 1):61-68. doi: 10.1007/s12055-023-01642-0. Epub 2023 Dec 19.
3
Successful Nafamostat Mesilate Administration for Andexanet Alfa-Induced Heparin Resistance.
甲磺酸萘莫司他成功用于治疗安多昔单抗诱导的肝素抵抗。
Cureus. 2023 Aug 23;15(8):e44003. doi: 10.7759/cureus.44003. eCollection 2023 Aug.
4
Inactive large cerebral hemorrhage is not exacerbated by the adjustment of anticoagulation post open-heart surgery.心脏直视手术后调整抗凝治疗不会使非活动性大脑出血加重。
J Cardiol Cases. 2021 May 13;24(4):186-189. doi: 10.1016/j.jccase.2021.04.003. eCollection 2021 Oct.